Federal funding for cancer research has led to significant advances in cancer prevention, detection, diagnosis, treatment, and quality of life for patients. More than 14.5 million survivors of cancer are alive in the United States today, largely because of the nation’s commitment to cancer research.
Despite this progress, federal funding for cancer research has remained flat for more than a decade. In inflation-adjusted dollars, the National Institutes of Health (NIH) budget was 20% lower in 2016 than it was a decade prior. Although Congress recently boosted NIH funds, sustained, increased funding is needed to regain momentum after years of inadequate support.
ASCO is urging Congress to continue to build on critical investments at the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Predictable and sustainable future funding increases will maintain the pace of scientific discovery, continue progress against cancer, and promote the development and delivery of new cancer therapies for millions of current and future patients.
- Visit our Cancer Progress section to learn about the last 50 years of progress against cancer.
- Read about research projects that received federal funding in our latest Clinical Care Advances report.